Rare Single-Gene Variants Confer High Risk for Mental Health Conditions, Geisinger Study Shows
Researchers suggest physicians should more routinely order genetic testing for patients with mental health disorders, a group that has historically been undertested.
Genomenon Partners With Neurodevelopmental Disease Groups on Drug Development
The Ann Arbor, Michigan-based bioinformatics company will provide AI-driven genomic data analysis in search of precision treatments for several rare pediatric disorders.
Dyslexia GWAS Leads to Dozens of Risk Loci, Polygenic Risk Score
A genome-wide association study that included more than a million cases or controls led to 42 genetic risk loci for dyslexia, along with a polygenic risk score.
Study Finds Metabolomic States Informing Common Disease Risk
After identifying disease-specific metabolomic states for 23 common conditions, researchers considered the predictive performance of the blood-based markers.
Researchers at NIH’s newly established Center for Alzheimer's and Related Dementias are using nanopore sequencing to analyze thousands of brain samples.